Isabelle Barber appointed to Exonhit management board
This article was originally published in Scrip
Exonhit, a biotech company focused on personalised medicine in oncology and Alzheimer's disease, has appointed Isabelle Barber, executive vice-president of global marketing for the diagnostics division, to its management board. Ms Barber joined Exonhit in 2010 as senior vice-president of global marketing and previously served at Ortho Clinical Diagnostics, a Johnson & Johnson company.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.